AR and ER interaction with a p21-activated kinase (PAK6)

Molecular Endocrinology

Volumn 16, Issue 1, 2002, Pages 85-99

  Lee, Suzanne R ^a   Ramos, Sharon M ^a   Ko, Andrew ^a   Masiello, David ^a   Swanson, Kenneth D ^a   Lu, Michael L ^b   Balk, Steven P ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANDROGEN RECEPTOR; BICALUTAMIDE; DNA; ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PROTEIN P21; PROTEIN P21 ACTIVATED KINASE 6; PROTEIN SERINE THREONINE KINASE; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; ENZYME ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HELA CELL; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; REPORTER GENE; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0036140025     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.1.0753     Document Type: Article

References (83)

1. Androgen receptor defects: Historical, clinical, and molecular perspectives
2. Mechanisms of androgen receptor activation and function
3. Treatment of androgen-independent prostate cancer
4. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist
5. Nuclear receptor coactivators
6. Nuclear receptor coregulators: Cellular and molecular biology
7. Increasing the complexity of coactivation in nuclear receptor signaling
8. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
9. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors
10. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
11. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
12. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains
13. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor
14. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer
15. Interaction between the amino- and carboxy-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
16. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2)
17. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain
18. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor
19. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
20. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
21. Rapid signalling by androgen receptor in prostate cancer cells
22. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
23. A brain serine/threonine protein kinase activated by Cdc42 and Rac1
24. A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20
25. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors
26. Pak to the future
27. A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases
28. MAP kinase pathways in yeast: For mating and more
29. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1
30. Activation of mitogen-activated protein kinase cascades by p21-activated protein kinases in cell-free extracts of Xenopus oocytes
31. Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck
32. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins
33. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak
34. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338
35. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells
36. Localization of p21-activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells
37. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia
38. Control of G2/M transition in Xenopus by a member of the p21-activated kinase (PAK) family: A link between protein kinase A and PAK signaling pathways?
39. Interaction of a G-protein β-subunit with a conserved sequence in Ste20/PAK family protein kinases
40. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2
41. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis
42. Cleavage and activation of p21-activated protein kinase γ-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity
43. p21-Activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis
44. Gelsolin, a multifunctional actin regulatory protein
45. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells
46. RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays
47. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin
48. An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors
49. Activation of an S6/H4 kinase (PAK 65) from human placenta by intramolecular and intermolecular autophosphorylation
50. Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway
51. PAK3 mutation in nonsyndromic X-linked mental retardation
52. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch
53. Interaction of the Nck adapter protein with p21-activated kinase (PAK1)
54. The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1
55. Mechanism of activation of Pak1 kinase by membrane localization
56. Reciprocal signaling between heterotrimeric G proteins and the p21-stimulated protein kinase
57. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
58. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer
59. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
60. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
61. Molecular basis of agonism and antagonism in the oestrogen receptor
62. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
63. Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription
64. A conserved negative regulatory region in αPAK: Inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1
65. Differential effects of PAK1-activating mutations reveal activity-dependent and -independent effects on cytoskeletal regulation
66. Identification of a central phosphorylation site in p21-activated kinase regulating autoinhibition and kinase activity
67. The human androgen receptor: Domain structure, genomic organization and regulation of expression
68. Rho GTPases as modulators of the estrogen receptor transcriptional response
69. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
70. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
71. Activation of androgen receptor function by a novel nuclear protein kinase
72. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
73. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription
74. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region
75. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function
76. Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6
77. A protein related to p21-activated kinase (PAK) that is involved in neurogenesis in the Drosophila adult central nervous system
78. PAK kinases are directly coupled to the PIX family of nucleotide exchange factors
79. A novel regulator of p21-activated kinases
80. Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes
81. Rho family GTPases bind to phosphoinositide kinases
82. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
83. Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1